| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.5M | +134.1% |
| Cost of Revenue | $8.4M | +162.1% |
| Gross Profit | $7.1M | +107.9% |
| R&D Expense | $45.8M | +57.3% |
| SG&A Expense | $58.5M | +27.9% |
| Operating Income | -$97.2M | -36.0% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $0 | — |
| Net Income | -$93.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.2M | -77.1% |
| Accounts Receivable | $4.3M | +72.9% |
| Inventory | $4.6M | +11.6% |
| Current Assets | $435.0M | +5.7% |
| Total Assets | $487.9M | -9.5% |
| Current Liabilities | $12.6M | -6.3% |
| Total Liabilities | $40.9M | +13.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.8M | -31.1% |
| Capital Expenditures | $10.3M | +48.3% |
| Investing Cash Flow | -$122.7M | +28.2% |
| Financing Cash Flow | $3.9M | -96.7% |
| Free Cash Flow | -$71.0M | -33.4% |
| -30.6% |
| EPS (Basic) | -$1.49 | -27.4% |
| EPS (Diluted) | -$1.49 | -27.4% |
| Stockholders' Equity |
| $447.0M |
| -11.1% |